Pyrimidine derivatives as orexin receptor antagonists
US7812031B2 · kind B2 · utility
12Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2006 |
| Grant date | Oct 12, 2010 |
| Priority date | — |
| Expiry date | Oct 31, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to substituted pyrimidine compounds of formula I useful as orexin receptor antagonists. The invention also relates to pharmaceutical compositions containing said compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.